Indicators

Markets:

News

Latest News about DMTTF

Recent news which mentions DMTTF

< Previous 1 2 3 4 5 Next >

Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD

January 06, 2024

Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoirs And More

October 29, 2023

Cybin's Deuterated Psychedelics Programs Protected By Three New International Patents

October 26, 2023

Cybin Officially Owns Small Pharma: Plans For New 'International Leader' In Psychedelic Therapeutics

October 23, 2023

Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted

October 22, 2023

Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business

October 20, 2023

Moving Closer To Cybin Acquisition, Small Pharma Obtains Final Order Approving Arrangement

October 18, 2023

Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More

October 16, 2023

Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates

October 13, 2023

Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More

October 02, 2023

Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results

September 26, 2023

Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More

September 26, 2023

Cybin Delivers Highest Dose Of Psilocybin Analog In Phase 2 For Major Depression

September 21, 2023

Billionaire Steve Cohen Invests $19M In Cybin For Psychedelics R&D, Blake Mycoskie's $100M Pledge Update

September 18, 2023

Cybin's Intellectual Powerhouse Grows With New US Patent Covering Deuterated 5-MeO-DMT

September 05, 2023

Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More

September 05, 2023

Mindset Pharma's $60M Acquisition, Otsuka's Leap Into Next-Gen Psychiatry Solutions

August 31, 2023

Second Psychedelics Merger Of The Week? Silo Wellness To Buy Jamaica-Based Business For $31.9M

August 29, 2023

Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety

August 28, 2023

Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More

August 03, 2023

Small Pharma's Q1 2024: Revamping Strategy And Potential Fast-Tracked Clinical Trial

July 28, 2023

Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More

July 11, 2023

Small Pharma Implements Costs Cut: New R&D Strategy And Management Team Change

July 05, 2023

Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More

July 04, 2023

Small Pharma Implements Cost-Cutting Strategy To Reduce Cash Burn As Trial Progresses

June 29, 2023

Psyched: LSD Microdosing For Depression, DMT For Anxiety, MDMA Octopuses And More

May 31, 2023

Small Pharma's IP Portfolio Grows With Numerous Approved Patent Applications Around The World

May 26, 2023

DMT For Major Depression Shows Remarkable Benefits After Six-Month Trial

April 04, 2023

EXCLUSIVE: NYC Ketamine Center Co-Founder On Prices, Insurance, Competition & Expansion

March 21, 2023

Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More

March 13, 2023

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.